|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| OTC Pharmaceuticals in Brazil |
|
|
|
|
€ 200,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2008 |
Taille du document : |
35 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
US Gastrointestinal Remedies 2004 12 pages | Novembre 2004 |
Snapdata's US Gastrointestinal Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US gastrointestinal |
240,00 €
|
| |
| |
US Antacids 2004 16 pages | Juillet 2004 |
Snapdata's US Antacids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US antacid market, and covers antacid |
240,00 €
|
| |
| |
US Lip Remedies 2004 13 pages | Juillet 2004 |
Snapdata's US Lip Remedies 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US lip remedy market, and covers |
240,00 €
|
| |
| |
US Acne Treatments 2004 14 pages | Juillet 2004 |
Snapdata's US Acne Treatments 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US acne treatments market.
|
240,00 €
|
| |
| |
US External Analgesics 2004 16 pages | Juillet 2004 |
Snapdata's US External Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US external analgesic mark |
240,00 €
|
| |
| |
US Laxatives 2004 12 pages | Novembre 2004 |
Snapdata's US Laxatives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US laxative market, and covers laxat |
240,00 €
|
| |
| |
US Smoking Cessation Aids 2004 13 pages | Juillet 2004 |
Snapdata's US Smoking Cessation Aids 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US smoking cessation ai |
240,00 €
|
| |
| |
The Biogenerics Market Outlook: An analysis of market dynamics, growth drivers and leading players 87 pages | Mars 2005 |
Branded biologic medicines generated an estimated $32bn of sales for the biotechnology and pharmaceutical industries and represented the fastest growing group of medicines; while continued high demand |
2 443,75 €
|
| |
| |
Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies 146 pages | Janvier 2005 |
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the mo |
2 443,75 €
|
| |
| |
US Vitamins & Minerals 2004 13 pages | Novembre 2004 |
Snapdata's US Vitamins & Minerals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts. The report gives an instant overview of the US vitamin and mineral mar |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| OTC Pharmaceuticals in Brazil |
|
|
Datamonitor's OTC Pharmaceuticals in Brazil industry profile is an essential resource for top-level data and analysis covering the otc pharmaceuticals industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information. Scope * Contains an executive summary and data on value, volume and/or segmentation
* Provides textual analysis of the industry’s recent performance and future prospects
* Incorporates in-depth five forces competitive environment analysis and scorecards * Includes a five-year forecast of the industry
* The leading companies are profiled with supporting key financial metrics * Supported by the key macroeconomic and demographic data affecting the market Highlights * Detailed information is included on market size, measured by both value and volume * Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
* Market shares are covered by manufacturer and/or brand
* Also features market breakdown by distribution channel Why you should buy this report * Spot future trends and developments * Inform your business decisions * Add weight to presentations and marketing materials * Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market values the total sales of analgesics, cough and cold preparations, indegestion preparations, topical OTC medicines, vitamins and minerals and other OTC healthcare products (anti-smoking aids, eye & ear drops, motion sickness medication, rectal medication and sleeping aids) at retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2006 annual average exchange rates.
For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.
|
|
TABLE OF CONTENTS EXECUTIVE SUMMARY 3 CHAPTER 1 Market Overview 7 1.1 Market Definition 7 1.2 Research Highlights 7 1.3 Market Analysis 8 CHAPTER 2 Market Value 9 CHAPTER 3 Market Segmentation I 10 CHAPTER 4 Market Segmentation II 11 CHAPTER 5 Market Share 12 CHAPTER 6 Five Forces Analysis 13 6.1 Summary 13 6.2 Buyer Power 14 6.3 Supplier Power 15 6.4 New Entrants 16 6.5 Substitutes 18 6.6 Rivalry 19 CHAPTER 7 Leading Companies 20 7.1 Pfizer Inc 20 7.2 GlaxoSmithKline Plc 23 7.3 Novartis AG 27 CHAPTER 8 Distribution 30 CHAPTER 9 Market Forecasts 31 9.1 Market Value Forecast 31 CHAPTER 10 Macroeconomic Indicators 32 CHAPTER 11 Appendix 34 11.1 Methodology 34 11.2 Industry Associations 35 11.3 Related Datamonitor Research 35 LIST OF TABLES Table 1: Brazil OTC Pharmaceuticals Market Value: $ billion, 2003-2007 9 Table 2: Brazil OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 10 Table 3: Brazil OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 11 Table 4: Brazil OTC Pharmaceuticals Market Share: % Share, by Value, 2007 12 Table 5: Key Facts: Pfizer Inc 20 Table 6: Key Financials: Pfizer Inc 22 Table 7: Key Facts: GlaxoSmithKline Plc 23 Table 8: Key Financials: GlaxoSmithKline Plc 26 Table 9: Key Facts: Novartis AG 27 Table 10: Key Financials: Novartis AG 29 Table 11: Brazil OTC Pharmaceuticals Distribution: % Share, by Value, 2007 30 Table 12: Brazil OTC Pharmaceuticals Market Value Forecast: $ billion, 2007-2012 31 Table 13: Brazil Size of Population (million) , 2003-2007 32 Table 14: Brazil GDP (Constant 2000 Prices, $ billion), 2003-2007 32 Table 15: Brazil Inflation, 2003-2007 32 Table 16: Brazil Exchange Rate, 2003 33
|
|
|
PPLSEN
|
|
|
|
|